All Type of News
Production gap between prescription and OTC drugs widens
Korea’s output gap in the share of both ethical drugs and OTCs in domestic pharmaceutical market has been widen, since the implementation of a new system of separating drug dispensing from medical practice in 2000, ca...
KFDA approves Requip PD tablets, once-daily non-ergot dopamine agonist
GlaxoSmithKline announced the approval of Requip PD (ropinirole extended-release tablets) in Korea for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The product will be available in pharma...
Former vice welfare minister named presidential secretaryPresident Lee Myung-bak has appointed Kang Yoon-koo, a former health-welfare vice minister and incumbent dean of SoonChunhyang University, as the senior secretary of social poli...
|
Korea Exchange OKs Myungmoon’s plan to join main bourseKorea's bourse operator Korea Exchange says that Myungmoon Pharm’s stocks will be listed in the KOSPI from July 10.
With its public listing in main bourse, the company’s fres...
|
Kukje looks to cosmetic market
Kukje Pharm has signed a memorandum of understanding with the US-based Stila Corporation to distribute Stila makeup brands in Korea.
The domestic makeup products market size is estimated at 180 billion won last yea...
Korea’s pharmaceutical output surpasses W13 tril. in 2007
The nation’s production of drugs, etc. amounted to 13.46 trillion won last year, up 9.7 percent from 2006, according to data released by the Korea Pharmaceutical Manufacturers Association.
Data showed that output o...
80% back prescription refill systemA majority of people favor prescription refill system for patients with chronic disease, according to a recent survey on June 19.
The survey, released by Seoul-based chapter ...
|
Lilly Korea opens wellness call center
Lilly Korea says it has opened its wellness call center to ensure a healthy balance of the mind-body and spirit that results in an overall feeling of well-being in patients with mental disorder.
According to the co...
Kwangdong to market new radiosensitizer in 2012
Kwangdong Pharm says it has signed an exclusive lisensing agreement with China-based Shandong Luye Pharmaceutical (SDLY) to develop and market a novel radiosensitizer “CMNa” in Korea.
CMNa is a new nitroimidazole ...
Insect-repellant market contested by 3 domestic pharmaceutical firms
Business sources say that the domestic household insect-repellant market valued at 7.0 billion won has emerged as an arena of tripartite competition among three pharmaceutical manufactures.
Hyundai Pharm says that...
